Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction: a Prospective, Multicentre, International Randomized Study

NCT06273280 is registered in ClinicalTrials.gov with Ziekenhuis Oost-Limburg as lead sponsor.

NCT NCT06273280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction: a Prospective, Multicentre, International Randomized Study
Lead sponsor
Ziekenhuis Oost-Limburg
Phase
Not applicable
Overall status
Unknown status
Start date
February 14, 2024
Completion date
March 31, 2026
Enrollment
345 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure with reduced ejection fraction